| __timestamp | BioCryst Pharmaceuticals, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 4534000000 |
| Thursday, January 1, 2015 | 72758000 | 5920000000 |
| Friday, January 1, 2016 | 61008000 | 4940000000 |
| Sunday, January 1, 2017 | 66962000 | 6411000000 |
| Monday, January 1, 2018 | 84888000 | 6345000000 |
| Tuesday, January 1, 2019 | 107068000 | 6148000000 |
| Wednesday, January 1, 2020 | 122964000 | 11143000000 |
| Friday, January 1, 2021 | 208808000 | 10195000000 |
| Saturday, January 1, 2022 | 253297000 | 9509000000 |
| Sunday, January 1, 2023 | 216566000 | 9299000000 |
| Monday, January 1, 2024 | 11159000000 |
Infusing magic into the data realm
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bristol-Myers Squibb Company and BioCryst Pharmaceuticals, Inc. have demonstrated contrasting yet intriguing R&D investment strategies.
From 2014 to 2023, Bristol-Myers Squibb consistently allocated substantial resources to R&D, peaking in 2020 with a staggering 11 billion dollars. This represents a 145% increase from their 2014 expenditure, underscoring their commitment to pioneering new treatments.
Conversely, BioCryst Pharmaceuticals, a smaller player, showed a remarkable 318% increase in R&D spending over the same period, reaching its zenith in 2022. This growth highlights their strategic focus on niche markets and innovative therapies.
These trends reflect the dynamic nature of pharmaceutical R&D, where both giants and emerging companies play crucial roles in advancing healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and BioCryst Pharmaceuticals, Inc.
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.